GSK Investigational Site

Nowy Sącz 33-300

0 studies enrolling now · 1 studies all time

What they study most

Multiple Myeloma

Studies at this site

• Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma — Running, not enrolling